Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company.
$16.51-1.26%
报价 2026-11-13
市值
$279.6M
EV
$238.9M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -37.1%
$11.79$26.25
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Medical - Diagnostics & Research| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| PREPrenetics Global Limited | $279.6M | -1.3% | – | 62.6% | – | – | – | |
| FLGTFulgent Genetics, Inc. | $689M | -0.8% | +3.3% | 33.8% | – | – | – | |
| ACRSAclaris Therapeutics, Inc. | $621.8M | -2.0% | -27.3% | 95.6% | – | – | – | |
| MYGNMyriad Genetics, Inc. | $542.9M | -0.4% | -4.7% | 68.8% | – | – | – | |
| TRIBTrinity Biotech plc | $123.5M | +3.7% | – | 38.5% | – | – | – | |
| STIMNeuronetics, Inc. | $108M | -2.8% | +8.8% | 50.7% | – | – | – | |
| XGNExagen Inc. | $105.4M | -6.3% | +7.7% | 58.6% | – | – | – | |
| BDSXBiodesix, Inc. | $80.4M | +0.9% | +29.1% | 63.9% | – | – | – | |
| SERASera Prognostics, Inc. | $78M | +1.5% | +300.0% | -191.2% | – | – | – | |
| 同行中位数 | – | – | +7.7% | 54.7% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。